SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-22-054716
Filing Date
2022-05-02
Accepted
2022-05-02 16:45:07
Documents
15
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm2213960d1_10ka.htm   iXBRL 10-K/A 317767
2 EXHIBIT 31.1 tm2213960d1_ex31-1.htm EX-31.1 4069
3 EXHIBIT 31.2 tm2213960d1_ex31-2.htm EX-31.2 4023
  Complete submission text file 0001104659-22-054716.txt   636648

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA hook-20211231.xsd EX-101.SCH 3286
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hook-20211231_def.xml EX-101.DEF 28679
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE hook-20211231_lab.xml EX-101.LAB 38833
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hook-20211231_pre.xml EX-101.PRE 27289
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2213960d1_10ka_htm.xml XML 6861
Mailing Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 0114318906360
HOOKIPA Pharma Inc. (Filer) CIK: 0001760542 (see all company filings)

IRS No.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38869 | Film No.: 22882714
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences